Intervention Review

You have free access to this content

Treatment of Lennox-Gastaut syndrome

  1. Eleanor C Hancock1,*,
  2. J Helen Cross2

Editorial Group: Cochrane Epilepsy Group

Published Online: 28 FEB 2013

Assessed as up-to-date: 15 JAN 2013

DOI: 10.1002/14651858.CD003277.pub3


How to Cite

Hancock EC, Cross JH. Treatment of Lennox-Gastaut syndrome. Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD003277. DOI: 10.1002/14651858.CD003277.pub3.

Author Information

  1. 1

    University of Liverpool, c/o Cochrane Epilepsy Group, Liverpool, UK

  2. 2

    The Wolfson Centre, UCL Institute of Child Health, London, UK

*Eleanor C Hancock, c/o Cochrane Epilepsy Group, University of Liverpool, Room 2.28, Clinical Sciences Centre, University Hospital Aintree, Lower Lane, Liverpool, L9 7LJ, UK. ellie.tom@virgin.net.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 28 FEB 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Anonymous 1989 {published data only}
  • Anonymous. Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut syndrome. The Group for the Evaluation of Cinromide in the Lennox-Gastaut syndrome. Epilepsia 1989;30(4):422-9. [MEDLINE: 89325225]
Anonymous 1993 {published data only}
  • Anonymous. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). The Felbamate Study Group in Lennox Gastaut syndrome. New England Journal of Medicine 1993;328(1):29-33. [MEDLINE: 93096004]
Conry 2009 {published data only}
Conry 2010 {published data only}
  • Conry J, Ng Y, Drummond R, Stolle J, Sagar S. Efficacy and safety of clobazam in the treatment of seizures associated with Lennox Gastaut syndrome: results of a phase III trial (abstract no: 1.283). Proceedings of the 64th Annual Meeting of the American Epilepsy Society. December 3-7, 2010, San Antonio, TX. www.aesnet.org/go/publications/aes-abstracts/abstract-search/mode/display/st/clobazam/sy/2010/sb/All/id/12483 (accessed 28 April 2012).
Eriksson 1998 {published data only}
  • Eriksson AS, Nergardh A, Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalised epilepsy: a randomised, double blind, crossover study. Epilepsia 1998;39(5):495-501.
Glauser 2008 {published and unpublished data}
Glauser 2009 {published data only}
  • Glauser T, Santana B V, Wang W, Narurkar M. Early and sustained response to rufinamide as adjunctive therapy for seizures associated with Lennox Gastaut syndrome. Epilepsia 2009;50 (suppl 11):261.
Inanaga 1989 {published data only}
Motte 1997 {published data only}
  • Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalised seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. New England Journal of Medicine 1997;337(25):1807-12. [MEDLINE: 98051155; : 1998002039]
Sachdeo 1999 {published data only}

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Jensen 1994 {published data only}
Vajda 1985 {published data only}
  • Vajda FJ, Bladin PF, Parsons BJ. Clinical experience with clobazam: a new 1,5 benzodiazepine in the treatment of refractory epilepsy. Clinical and Experimental Neurology 1985;21:177-82. [MEDLINE: 87188404]
Vassella 1978 {published data only}
  • Vassella F, Rudeberg A, Da Silva V, Pavlincova E. Double-blind study on the anticonvulsive effect of phenobarbital and valproate in the Lennox syndrome [Doppletblind-Untersuchung uber die antikonvulsive Wirkung von Phenobarbital und Valproat beim Lennox-Syndrom]. Schweizerische Medizinische Wochenschrift 1978;108(19):713-6. [MEDLINE: 78321217]

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
Aicardi 1996
  • Aicardi J. Lennox-Gastaut syndrome. In: Wallace editor(s). Epilepsy in Children. First Edition. London: Chapman & Hall Medical, 1996:249-62.
Arzimanoglou 2009
  • Arzimanoglou A, French J, Blume WT, Cross J, Ernst JP, Feucht M, et al. Lennox Gastaut Syndrome: a consensus approach on diagnosis, assessment, management and trial methodology. Lancet Neurology 2009;8(1):82-93.
Beaumanoir 2005
  • Beaumanoir A, Blume W. The Lennox-Gastaut syndrome. In: Roger J, Bureau M, Dravet C, Tassinari C, Wolf P editor(s). Epileptic Syndromes in Infancy, Childhood and Adolescence. 4th Edition. London: John Libby Eurotext, 2005:125-48.
Berg 2011
European Union 2006
  • The European Parliament and the Council of the European Union. Regulation (EC) No 1901/2006 of the European Council and of the Council of 12th December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. www.emea.europa.eu/htms/human/paediatrics/regulation.htm 2006.
Lefebvre 2009
  • Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org.
Patwardhan 2000